Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely produced TPD techniques. With this critique, we target the two preclinical experiments and clinical trials to offer an extensive summary of the safety and medical efficiency of PROTACs and MGDs in hematologic malignancies in the last 20 https://squalene00987.bloguetechno.com/abbv-744-no-further-a-mystery-67016505